Z-2751-2017 Class II Terminated
FDA device recall Z-2751-2017 was initiated by Becton Dickinson & Company on Sep 16, 2016 and is designated Class II. Reason for recall: BD identified that several lots did not receive the specified dose of irradiation necessary to meet the Sterility Assurance Level (SAL) required of 10-6. The recall status is terminated (terminated Mar 20, 2018). Affected quantity: 648,000 units.
Recall details
- Product Type
- Devices
- Report Date
- Jul 26, 2017
- Initiation Date
- Sep 16, 2016
- Termination Date
- Mar 20, 2018
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 648,000 units
Product description
BD 3ml Syringe Luer-Lok" Tip Catalog 309657 The BD Single Use, Hypodermic Syringe is intended for use by health care professionals for general purpose fluid aspiration/injection
Reason for recall
BD identified that several lots did not receive the specified dose of irradiation necessary to meet the Sterility Assurance Level (SAL) required of 10-6.
Distribution pattern
Nationwide Distribution
Code information
6061746 2021-02 6082982 2021-02 6089821 2021-03 6117858 2021-04 6117863 2021-04 6117889 2021-04 6117891 2021-04 6146962 2021-04 6173697 2021-05 6173767 2021-06 6173779 2021-06 6208614 2021-07
Source
- Dataset
- openFDA device recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for Z-2751-2017
- openFDA file date
- Nov 16, 2026
- Loaded by RegDataLab
- Nov 17, 2026